NCT00050674View on ClinicalTrials.gov

Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

Filgrastim-SD/01

6 mg SC on Day 9 (24 hours after the end of the chemotherapy infusion)

Trial Locations (2)

38120

The West Clinic, PC, Memphis

38671

The West Clinic, PC, Southaven

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Schwartzberg, Lee, M.D.

INDIV

NCT00050674 - Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma | Biotech Hunter | Biotech Hunter